These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 588821)

  • 1. The inhibition of human heart monoamine oxidase [proceedings].
    Callingham BA; Parkinson D
    Br J Pharmacol; 1977 Nov; 61(3):470P-471P. PubMed ID: 588821
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential development, inhibition, and recovery of monoamine oxidase in various parts of the rat heart.
    Horita A
    Res Commun Chem Pathol Pharmacol; 1970 Nov; 1(6):713-20. PubMed ID: 5524271
    [No Abstract]   [Full Text] [Related]  

  • 3. Some effects of age upon irreversible inhibition of cardiac MAO.
    Callingham BA; Lyles GA
    Br J Pharmacol; 1975 Mar; 53(3):458P-459P. PubMed ID: 1137756
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitroglycerin (glyceryl trinitrate) as a monoamine oxidase inhibitor.
    Ogawa K; Gudbjarnason S; Bing RJ
    J Pharmacol Exp Ther; 1967 Mar; 155(3):449-55. PubMed ID: 4960617
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Mechanism of antidepressant efficacy of monoamine oxidase inhibitors: inhibition of monoamine oxidase or of catecholamine reuptake.
    Snyder SH
    Psychopharmacol Bull; 1974 Oct; 10(4):16. PubMed ID: 4431859
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective inhibition of monoamine oxidase.
    Fuller RW
    Adv Biochem Psychopharmacol; 1972; 5():339-54. PubMed ID: 4559891
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 10. Metaraminol and monoamineoxidase activity in the rat heart.
    Bareggi SR; Carminati P; Manara L
    Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):347-54. PubMed ID: 5149892
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine oxidase (MAO) activity in the rat heart after a single dose of ethyl alcohol.
    Pieczul J; Samochowiec L; Wójcicki J
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):267-9. PubMed ID: 5420947
    [No Abstract]   [Full Text] [Related]  

  • 12. Is metaraminol a selective monoamine oxidase inhibitor?
    Manara L; Carminati P
    Adv Biochem Psychopharmacol; 1972; 5():421-2. PubMed ID: 5054211
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple forms of monoamine oxidase (author's transl)].
    Kaminski K; Matuszewski W
    Postepy Biochem; 1975; 21(4):369-82. PubMed ID: 810780
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of brain monoamine oxidase by 1,2,4-trisubstituted 5-imidazolones.
    Kumar S; Pandey BR; Parmar SS; Gallagher JR; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):163-6. PubMed ID: 6729247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Mar; 50(3):443P-446P. PubMed ID: 4277620
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Monoamine oxidase from rat reticulocytes: subcellular localization of the enzyme activity and effects of irreversible non-hydrazine inhibitors.
    Quiring K; Hubertus S
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R83. PubMed ID: 1143505
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacologic characteristics of monoamine oxidase inhibitors: problems related to their use in the treatment of angina].
    Simon P
    Therapie; 1970; 25(2):343-8. PubMed ID: 5526213
    [No Abstract]   [Full Text] [Related]  

  • 18. On the extraneuronal nature of cardiac monoamine oxidase in the rat.
    Horita A; Lowe MC
    Adv Biochem Psychopharmacol; 1972; 5():227-42. PubMed ID: 5054204
    [No Abstract]   [Full Text] [Related]  

  • 19. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid.
    Knopp J
    Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.